L-Glutamine Oral Therapy Reduces Sickle Cell-Related Pain Better Than Placebo

관련뉴스

1. Therapy with L-Glutamine reduces pain in patients with sickle cell disease UCSF Benioff Children’s Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both … Date : 2018-07-27T12:56:00.000Z Source : https://www.news-medical.net/news/20180727/Therapy-with-L-Glutamine-reduces-pain-in-patients-with-sickle-cell-disease.aspx...
   
   
2. How stem cell therapy helps sickle cell disease sufferers Jumua, 11, was born with sickle cell disease. Her parents spent an average of N70, 000 whenever she had any crisis associated with the disease. Her family said they knew no peace and rest ever since her birth, till she underwent stem cell transplant at … (본문 전체 8/22/2018 12:09 AM)...
   
   
3. Hope for sickle cell disease patients after promising gene therapy breakthrough A cure for sickle cell disease could soon be available for patients with severe forms of the disease after scientists made a major breakthrough in a promising new kind of genetic treatment. (본문 전체 11/18/2018 1:35 AM)...
   
   
4. Gene Therapy for Sickle-Cell Diseases| a Drug Pipeline Analysis Report 2018| Technavio LONDON–(BUSINESS WIRE)–Technavio has announced their latest pipeline analysis report on gene therapy for sickle-cell diseases. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period … Date : 2018-07-25T22:44:00.000Z Source : https://www.businesswire.com/news/home/20180725005688/en/Gene-Therapy-Sickle-Cell-Diseases-Drug-Pipeline-Analysis...
   
   
5. Imara’s Sickle Cell Disease Therapy Impresses in Phase 2 Trial Boston-based biotech, Imara Inc. announced promising Phase2a trial results of its Sickle Cell Disease Drug, IMR-687. When compared to the placebo, IMR-687 was well tolerated as a [전체본문 2021-01-09 04:05:00Z]...
   
   
6. How Stem Cell Therapy Could Take Your Pain Away Dr. Robert Bean Utah Pain Relief Institute & My Stem Cell USA stopped by to tell us about how stem cell technology are relieving pain and other common conditions. Dr. Bean tells us that stem … (본문 전체 9/12/2018 10:46 AM)...
   
   
7. Chronic Pain? Use Your Own Body to Treat It via Stem Cell Therapy If you suffer from chronic pain or another chronic condition, you may have tried everything in order to manage your illness. But have you tried stem cell therapy? Robert Bean, DC, from Utah Pain Relief Institute & My Stem Cell USA came on the show today to … (본문 전체 8/4/2018 8:35 AM)...
   
   
8. Can Growth Factors with Stem Cell Therapy Help Reduce My Arthritis Pain? NEW YORK, N.Y. and GREENWICH, Conn., July 30, 2018 /PRNewswire-PRWeb/ — When pain relievers just don’t reduce your arthritis pain enough and you’re contemplating a big step – such as joint replacement surgery – it may be time to consider the … (본문 전체 7/31/2018 5:43 PM)...
   
   
9. CAR T-cell therapy ‘quite promising’ for glioblastoma Chimeric antigen receptor T-cell therapy may overcome some of the obstacles associated with systemic therapy for patients with glioblastoma, according to a review published in Neuro-Oncology. Although progress with chimeric antigen receptor (CAR) T-cell … Date : 2018-07-17T14:08:00.000Z Source : https://www.healio.com/hematology-oncology/neuro-oncology/news/online/%7B66c3e2bc-9965-45f7-8d5b-4cf21f380777%7D/car-t-cell-therapy-quite-promising-for-glioblastoma...
   
   
10. The Curative Potential of CAR-T Cell Therapy in Mantle Cell Lymphoma Though it is still being tested in clinical trials, CAR-T cell therapy can offer hope for patients with mantle cell lymphoma whose disease relapsed. BY Andre Goy, M.D., M.S. PUBLISHED July 26, 2018 Chimeric antigen receptor (CAR)-T cell therapy is … Date : 2018-07-26T15:40:00.000Z Source : https://www.curetoday.com/cure-tv/the-curative-potential-of-car-t-cell-therapy-in-mantle-cell-lymphoma...
    
    
11. Trial to assess feasibility, safety of CAR T-cell therapy for relapsed pediatric central nervous system tumors A clinical trial is underway to examine the role of chimeric antigen receptor T-cell therapy for children and young adults with relapsed or refractory HER-2-positive central nervous system tumors. “[Although] survival rates have improved for pediatric … Date : 2018-07-20T20:13:00.000Z Source : https://www.healio.com/hematology-oncology/pediatric-oncology/news/online/%7B44476930-4812-4055-b018-a13f80b607af%7D/trial-to-assess-feasibility-safety-of-car-t-cell-therapy-for-relapsed-pediatric-central-nervous-system-tumors...
    
    
12. FDA lifts hold on Vertex and CRISPR Therapeutics sickle cell therapy The FDA has lifted the clinical hold on the trial of a CRISPR gene-editing therapy CTX001 in patients with of sickle cell disease (SCD), enabling partners Vertex and CRISPR Therapeutics to begin the study by the end of 2018. The US regulator placed a hold … (본문 전체 10/12/2018 8:18 PM)...
    
    
13. Promising approach to stem cell therapy for treating Parkinson’s disease A major factor underlying Parkinson’s Disease (PD) pathology is the loss of dopamine neurons in the substantia nigra, and thus current therapies often aim to restore dopamine signaling. However, these treatments are not curative. The most promising … Date : 2018-07-24T08:00:00.000Z Source : https://www.news-medical.net/news/20180724/Promising-approach-to-stem-cell-therapy-for-treating-Parkinsons-disease.aspx...
    
    
14. Wait and see…when do we “escalate” care for low back pain? Prompted by reading a paper by Linton, Nicholas and Shaw (in press), today’s post is about various service delivery models for low back pain and not the content of back pain treatment. Service delivery in New Zealand is assumed to be based on getting … (Source 10/28/2018 5:19 PM)...
    
    
15. Psychotherapy for Chronic Pain Chronic pain treatment: Psychotherapy, not opioids, has been proven to work – Vox – By Brian Resnick @B_resnick brian@vox.com – Aug 16, 2018 When pain settled into Blair Golson’s hands, it didn’t let go. What started off as light throbbing in … (Source 11/4/2018 3:14 PM)...
    
    
16. First HCT Following CAR T-Cell Therapy Reduces Risk for ALL Relapse Receiving a stem cell transplant for the first time following CD19 CAR T-cell therapy induced a reduction in the risk for acute lymphoblastic leukemia (ALL) recurrence, according to a retrospective analysis of the phase I/II PLAT-02 study. 1 However, those … (본문 전체 12/2/2018 12:23 PM)...
    
    
17. Mesoblast’s stem cell therapy reduces GI bleeding but misses endpoint in end-stage HF trial PERTH, Australia – Australian regenerative medicine company Mesoblast Ltd.’s allogeneic cell therapy candidate, MPC-150-IM, failed to meet the primary endpoint in a phase IIb trial in end-stage heart failure patients implanted with a left ventricular … (본문 전체 11/13/2018 2:57 PM)...
    
    
18. Gene editing may enhance CAR T-cell therapy for hematologic malignancies Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have used gene editing technology known as CRISPR to engineer human T cells to attack certain cancers. Results from studies conducted … Date : 2018-07-17T20:39:00.000Z Source : https://www.healio.com/hematology-oncology/leukemia/news/online/%7B36c82695-07c0-4de6-88a1-db5aba5043cf%7D/gene-editing-may-enhance-car-t-cell-therapy-for-hematologic-malignancies...
    
    
19. $3.1 Bn Sickle Cell Disease Market Insights, Epidemiology and Market Forecast 2017-2025 – ResearchAndMarkets.com which will give more patient access to this therapy. United States contributes the major share of Sickle Cell Disease market as compared to EU5 countries. (본문 전체 9/11/2018 9:02 PM)...
    
    
20. Stem Cell Therapy for Pain and Stem Cell Health Centers You would likely think that I really enjoy writing about the stem cell wild west or the explosion in scams related to regenerative medicine. I really don’t, as there’s usually something better I need to do. Hence, I only write when I see something … (본문 전체 8/13/2018 9:42 PM)...